"The premiere retina group in the Tampa Bay area. We are fellowship trained Retina specialists providing care of simple and complex retinal diseases of the eye, including diabetic eye care, macular degeneration, surgical care of retinal conditions, and cutting edge clinical trials."

During the past decade, Retina Vitreous Associates of Florida conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 18 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 17 clinical trials were completed. i.e. 68% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Vitreous Associates of Florida" #1 sponsor was "Hoffmann-La Roche" with 18 trials, followed by "Allergan" with 4 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "Gyroscope Therapeutics Limited" with 4 trials sponsored and "Kodiak Sciences Inc" with 4 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Vitreous Associates of Florida" #1 collaborator was "Novartis Pharmaceuticals" with 4 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "MEDARVA Foundation" with 1 trials as a collaborator and "Ocular Therapeutix, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Retina Vitreous Associates of Florida" are "Geographic Atrophy" (11 trials), "Diabetic Macular Edema" (9 trials), "Macular Degeneration" (9 trials), "Macular Edema" (5 trials) and "Neovascular Age-related Macular Degeneration" (5 trials). Many other conditions were trialed in "Retina Vitreous Associates of Florida" in a lesser frequency.

Most popular intervention types in "Retina Vitreous Associates of Florida" are "Drug" (43 trials), "Other" (13 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (15 trials), "Faricimab" (9 trials), "Ranibizumab" (9 trials), "Aflibercept" (7 trials) and "KSI-301" (4 trials). Other intervention names were less common.

The vast majority of trials in "Retina Vitreous Associates of Florida" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Retina Vitreous Associates of Florida". undefined are not yet recruiting, 6 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Retina Vitreous Associates of Florida, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Vitreous Associates of Florida, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".